38474465|t|Neuroprotective Effects of Polysaccharides and Gallic Acid from Amauroderma rugosum against 6-OHDA-Induced Toxicity in SH-SY5Y Cells.
38474465|a|The pharmacological activity and medicinal significance of Amauroderma rugosum (AR) have rarely been documented. We examined the antioxidant and neuroprotective effects of AR on 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in an SH-SY5Y human neuroblastoma cell model of Parkinson's disease (PD) and explored the active ingredients responsible for these effects. The results showed that the AR aqueous extract could scavenge reactive oxygen species and reduce SH-SY5Y cell death induced by 6-OHDA. In addition, the AR aqueous extract increased the survival of Caenorhabditis elegans upon juglone-induced toxicity. Among the constituents of AR, only polysaccharides and gallic acid exhibited antioxidant and neuroprotective effects. The AR aqueous extract reduced apoptosis and increased the expression of phospho-Akt, phospho-mTOR, phospho-MEK, phospho-ERK, and superoxide dismutase-1 in 6-OHDA-treated SH-SY5Y cells. The polysaccharide-rich AR extract was slightly more potent than the aqueous AR extract; however, it did not affect the expression of phospho-Akt or phospho-mTOR. In conclusion, the AR aqueous extract possessed antioxidant and neuroprotective properties against 6-OHDA-induced toxicity in SH-SY5Y cells. The mechanism of action involves the upregulation of the Akt/mTOR and MEK/ERK-dependent pathways. These findings indicate the potential utility of AR and its active ingredients in preventing or treating neurodegenerative disorders associated with oxidative stress such as PD.
38474465	27	42	Polysaccharides	Chemical	MESH:D011134
38474465	47	58	Gallic Acid	Chemical	MESH:D005707
38474465	64	83	Amauroderma rugosum	Species	483017
38474465	92	98	6-OHDA	Chemical	MESH:D016627
38474465	107	115	Toxicity	Disease	MESH:D064420
38474465	119	126	SH-SY5Y	CellLine	CVCL:0019
38474465	193	212	Amauroderma rugosum	Species	483017
38474465	214	216	AR	Species	483017
38474465	306	308	AR	Species	483017
38474465	312	329	6-hydroxydopamine	Chemical	MESH:D016627
38474465	331	337	6-OHDA	Chemical	MESH:D016627
38474465	347	360	neurotoxicity	Disease	MESH:D020258
38474465	367	374	SH-SY5Y	CellLine	CVCL:0019
38474465	375	380	human	Species	9606
38474465	409	428	Parkinson's disease	Disease	MESH:D010300
38474465	430	432	PD	Disease	MESH:D010300
38474465	529	531	AR	Species	483017
38474465	563	586	reactive oxygen species	Chemical	MESH:D017382
38474465	598	605	SH-SY5Y	CellLine	CVCL:0019
38474465	628	634	6-OHDA	Chemical	MESH:D016627
38474465	653	655	AR	Species	483017
38474465	698	720	Caenorhabditis elegans	Species	6239
38474465	726	733	juglone	Chemical	MESH:C005134
38474465	742	750	toxicity	Disease	MESH:D064420
38474465	778	780	AR	Species	483017
38474465	787	802	polysaccharides	Chemical	MESH:D011134
38474465	807	818	gallic acid	Chemical	MESH:D005707
38474465	874	876	AR	Species	483017
38474465	951	954	Akt	Gene	207
38474465	964	968	mTOR	Gene	2475
38474465	978	981	MEK	Gene	5609
38474465	991	994	ERK	Gene	5594
38474465	1000	1022	superoxide dismutase-1	Gene	6647
38474465	1026	1032	6-OHDA	Chemical	MESH:D016627
38474465	1041	1048	SH-SY5Y	CellLine	CVCL:0019
38474465	1060	1074	polysaccharide	Chemical	MESH:D011134
38474465	1080	1082	AR	Species	483017
38474465	1133	1135	AR	Species	483017
38474465	1198	1201	Akt	Gene	207
38474465	1213	1217	mTOR	Gene	2475
38474465	1238	1240	AR	Species	483017
38474465	1318	1324	6-OHDA	Chemical	MESH:D016627
38474465	1333	1341	toxicity	Disease	MESH:D064420
38474465	1345	1352	SH-SY5Y	CellLine	CVCL:0019
38474465	1417	1420	Akt	Gene	207
38474465	1421	1425	mTOR	Gene	2475
38474465	1430	1433	MEK	Gene	5609
38474465	1434	1437	ERK	Gene	5594
38474465	1507	1509	AR	Species	483017
38474465	1563	1590	neurodegenerative disorders	Disease	MESH:D019636
38474465	1632	1634	PD	Disease	MESH:D010300
38474465	Positive_Correlation	MESH:C005134	MESH:D064420
38474465	Positive_Correlation	MESH:D016627	MESH:D020258
38474465	Positive_Correlation	MESH:D016627	MESH:D064420
38474465	Negative_Correlation	MESH:D005707	MESH:D016627

